Search Results

You are looking at 1 - 10 of 2,222 items for :

  • "screening" x
  • Refine by Access: All Content x
Clear All
Orvosi Hetilap
Authors: Péter Barta and György Losonczy

Strauss, G. M., Gleason, R. E., Sugarbaker, D. J.: Chest X-ray screening improves outcome in lung cancer. A reappraisal of randomized trials on lung cancer screening. Chest, 1995, 107 (Suppl. 6

Open access

References [1]. L. Esserman Y. Shieh I. Thompson 2009 Rethinking screening for breast cancer and prostate cancer JAMA 302 1685 – 1692 . [2]. A. Kovács L. Döbrőssy A. Budai I. Boncz A. Cornides 2007

Restricted access
Orvosi Hetilap
Authors: Andrea Szabó, Bálint Alasztics, Ferenc Bánhidy, and Sándor Valent

Nicolaides, K. H.: Screening for fetal aneuploidies at 11 to 13 weeks. Prenat. Diagn., 2011, 31 , 7–15. Nicolaides K. H. Screening for fetal aneuploidies at 11 to 13 weeks

Open access

Esserman, L., Shieh, Y., Thompson, I.: Rethinking screening for breast cancer and prostate cancer. JAMA, 2009, 302 , 1685–1692. Thompson I

Restricted access
Journal of Behavioral Addictions
Authors: Gaëlle Challet-Bouju, Bastien Perrot, Lucia Romo, Marc Valleur, David Magalon, Mélina Fatséas, Isabelle Chéreau-Boudet, Amandine Luquiens, JEU Group, Marie Grall-Bronnec, and Jean-Benoit Hardouin

) questionnaires is the Canadian Problem Gambling Inventory (CPGI) ( Ferris & Wynne, 2001 ). Finally, examples of brief (1–3 items) screening tools are the one-item Screen for Problem Gambling (one-item SPG) ( Thomas, Piterman, & Jackson, 2008 ), the Lie

Open access

Guideline of the Ministry of Health for mammographic screening and early breast cancer detection – 2008. [Az Egészségügyi Minisztérium szakmai protokollja a mammográfiás emlőszűrésről és a korai emlőrák diagnosztikájáról – 2008.] http

Restricted access

” or “disordered” gamers using one of the many available screening instruments that have been created over the last two decades ( King et al., 2020 ). Some commentators have criticized the evidence as “weak” ( van Rooij et al. 2018 , p. 6), and raised

Open access

Pediatric Ophthalmology and Strabismus, and the American Academy of Ophthalmology: Screening examinations of premature infants for retinopathy of prematurity. Pediatrics, 2001, 108 , 809. Screening examinations of premature

Restricted access
Journal of Thermal Analysis and Calorimetry
Authors: R. Hilfiker, J. Berghausen, F. Blatter, A. Burkhard, S. De Paul, B. Freiermuth, A. Geoffroy, U. Hofmeier, C. Marcolli, B. Siebenhaar, M. Szelagiewicz, A. Vit, and M. von Raumer

Abstract  

Crystal structure (polymorphism) as well as crystal shape (morphology) and size have a huge practical and commercial impact on active substances all the way from research to manufacture of the final product. For an optimal development process, it is important to have an integrated approach to these issues ranging from a systematic polymorphism screening to a controlled scale-up of the crystallization process. The polymorphism program has to be tailored according to the development stage. Particularly suitable for an early development stage is a high-throughput polymorphism screening, which is the basis for a more thorough investigation if the product proceeds further in development. Such a comprehensive polymorphism investigation involves further crystallization experiments and extensive physicochemical characterization of the various forms. In this article the high-throughput polymorphism screening method that we have developed is described. Using carbamazepine as an example, the power of this high-throughput polymorphism screening system is demonstrated. Not only were all published forms found, but also new forms were identified. In the second part of the article, important considerations for crystallization optimization are discussed, again using the example of carbamazepine.

Restricted access

and MRSA infections are associated with significant healthcare costs [ 4 ]. Guidelines and recommendations [ 5 ], as well as hospital standard procedures, recommend active screening and isolation and/or decolonization of patients as measures to control

Open access